Obstructive Sleep Apnea (OSAS)
Conditions
Brief summary
Obstructive Sleep Apnea Syndrome (OSAS) is a chronic disease characterized by intermittent hypoxia and sleep fragmentation resulting from recurrent upper airway obstructions. The physiological and neurocognitive changes caused by the disease can affect how individuals perceive and interpret bodily sensations. Although body awareness plays a significant role in the perception and management of symptoms, its relationship with clinical parameters in individuals with OSAS has not been sufficiently investigated. Therefore, the aim of our study is to examine the relationship between body awareness and respiratory function, disease severity, fatigue, shortness of breath, and sleep quality in OSAS patients.
Interventions
None listed
Sponsors
Karabuk University
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Receiving a diagnosis of OSA after polysomnography, * Having an Apnea-Hypopnea Index ≥5 for OSA, * Volunteering to participate in the study.
Exclusion criteria
* Having severe orthopedic, neurological, or cardiac diseases, * Having a diagnosed lung disease, * Having a previous or current history of psychiatric or neurological disorders, * Not voluntarily participating in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Body awareness | Baseline | The Body Awareness Questionnaire (BAQ) will be used to assess individuals' body awareness. The scale score ranges from 18 to 26, with higher scores indicating higher awareness. |
| Dyspnea | Baseline | Dyspnea is assessed with the modified Medical Research Council (mMRC) dyspnea scale. As the score increases, shortness of breath increases. |
| Disease severity | Baseline | The evaluation will be based on the Apnea/Hypopnea index measured by polysomnography. An Apnea-Hypopnea Index \>5 indicates Obstructive Sleep Apnea Syndrome. |
| Fatigue severity | Baseline | Fatigue will be assessed using the Fatigue Severity Scale. A score of 36 or higher indicates severe fatigue. |
| Sleep quality | Baseline | Sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PUKI). The total score ranges from 0 to 21, and a score above 5 indicates poor sleep quality. |
| Pulmonary function (Forced vital capacity (FVC) | Baseline | Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Forced vital capacity (FVC) will be measured. |
| Pulmonary function (Forced expiratory volume in the first second (FEV1) | Baseline | Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Forced expiratory volume in the first second (FEV1) will be measured. |
| Pulmonary function (FEV1 / FVC) | Baseline | Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. FEV1 / FVC will be measured. |
| Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) | Baseline | Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Flow rate 25-75% of forced expiratory volume (FEF 25-75%) will be measured. |
| Pulmonary function (Peak flow rate (PEF)) | Baseline | Pulmonary function will be evaluated using the spirometry, according to American Thoracic Society and European Respiratory Society criteria. Peak flow rate (PEF) will be measured. |
Countries
Turkey (Türkiye)
Contacts
CONTACTMusa Güneş, PhD
PRINCIPAL_INVESTIGATORMusa Güneş, PhD
Karabuk University
Outcome results
None listed